MedTrace Logo

Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)

NCT01088217 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2020-09-14

No results posted yet for this study

Summary

The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis. Finding the genes that cause pulmonary fibrosis is the first step at developing better methods for early diagnosis and improved treatment for pulmonary fibrosis. The overall hypothesis is that inherited genetic factors predispose individuals to develop pulmonary fibrosis.

Conditions

Sponsors & Collaborators

  • University of Colorado, Denver

    collaborator OTHER

  • Vanderbilt University

    collaborator OTHER

  • Landspitali University Hospital

    collaborator OTHER

  • National Jewish Health

    lead OTHER

Principal Investigators

  • David A. Schwartz, MD · University of Colorado Denver; National Jewish Health

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • United States
  • Iceland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01088217 on ClinicalTrials.gov